Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

ORKA holding history

Oruka Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ORKA overviewAll 13F holders of ORKAFull Q4 2025 holdings

Shares (Q4 2025)
2,453,530
Value
$74.4M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ORKA by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20252,453,530$74.4M<0.1%+676,865+38.1%AddedHolders
Q3 20251,776,665$34.2M<0.1%−40,642−2.2%ReducedHolders
Q2 20251,817,307$20.4M<0.1%+179,874+11.0%AddedHolders
Q1 20251,637,433$16.8M<0.1%+26,782+1.7%AddedHolders
Q4 20241,610,651$31.2M<0.1%+1,572,853+4,161.2%AddedHolders
Q3 202437,798$926.4K<0.1%−415,800−91.7%ReducedHolders
Q2 2024453,598$1.74M<0.1%00.0%UnchangedHolders
Q1 2024453,598$798.3K<0.1%00.0%UnchangedHolders
Q4 2023453,598$771.1K<0.1%+3,063+0.7%AddedHolders
Q3 2023450,535$905.6K<0.1%−11,078−2.4%ReducedHolders
Q2 2023461,613$937.1K<0.1%−5,592−1.2%ReducedHolders
Q1 2023467,205$929.7K<0.1%+7,800+1.7%AddedHolders
Q4 2022459,405$1.09M<0.1%+235+0.1%AddedHolders
Q3 2022459,170$946.0K<0.1%−1,048−0.2%ReducedHolders
Q2 2022460,218$1.15M<0.1%+656+0.1%AddedHolders
Q1 2022459,562$1.06M<0.1%+53,279+13.1%AddedHolders
Q4 2021406,283$874.0K<0.1%−10,975−2.6%ReducedHolders
Q3 2021417,258$1.24M<0.1%+18,751+4.7%AddedHolders
Q2 2021398,507$1.39M<0.1%+261,009+189.8%AddedHolders
Q1 2021137,498$502.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.